These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20402961)

  • 1. Letter: vasculitis related to non-animal hyaluronic acid skin filler injection.
    Alijotas-Reig J
    Dermatol Surg; 2010 Feb; 36(2):272-3. PubMed ID: 20402961
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid.
    Arron ST; Neuhaus IM
    J Cosmet Dermatol; 2007 Sep; 6(3):167-71. PubMed ID: 17760694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent urticarial vasculitis related to nonanimal hyaluronic acid skin filler injection.
    Alijotas-Reig J
    Dermatol Surg; 2009 Feb; 35 Suppl 1():395-7; discussion 397-8. PubMed ID: 19207332
    [No Abstract]   [Full Text] [Related]  

  • 4. Salvage of nasal skin in a case of venous compromise after hyaluronic acid filler injection using prostaglandin E.
    Kim SG; Kim YJ; Lee SI; Lee CJ
    Dermatol Surg; 2011 Dec; 37(12):1817-9. PubMed ID: 22182239
    [No Abstract]   [Full Text] [Related]  

  • 5. Foreign body reaction to hyaluronic acid filler injection: in search of an etiology.
    Mamelak AJ; Katz TM; Goldberg LH; Graves JJ; Kaye VN; Friedman PM
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1701-3. PubMed ID: 19807767
    [No Abstract]   [Full Text] [Related]  

  • 6. Fast and easy treatment for reduction of the Tyndall effect secondary to cosmetic use of hyaluronic acid.
    Douse-Dean T; Jacob CI
    J Drugs Dermatol; 2008 Mar; 7(3):281-3. PubMed ID: 18380210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA -- Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001.
    André P
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):422-5. PubMed ID: 15196154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid.
    Hirsch RJ; Brody HJ; Carruthers JD
    J Cosmet Laser Ther; 2007 Sep; 9(3):182-5. PubMed ID: 17763028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioedema after ovine hyaluronidase injection for treating hyaluronic acid overcorrection.
    Andre P; Fléchet ML
    J Cosmet Dermatol; 2008 Jun; 7(2):136-8. PubMed ID: 18482018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diplopia after hyaluronic acid gel injection for correction of facial tear trough deformity.
    Kashkouli MB; Heirati A; Pakdel F; Kiavash V
    Orbit; 2012 Oct; 31(5):330-1. PubMed ID: 22571493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interesting reaction to a high- and low-molecular weight combination hyaluronic acid.
    Goodman GJ
    Dermatol Surg; 2015 Apr; 41 Suppl 1():S164-6. PubMed ID: 25828043
    [No Abstract]   [Full Text] [Related]  

  • 12. Eosinophilic granulomatous reaction after intradermal injection of hyaluronic acid.
    Okada S; Okuyama R; Tagami H; Aiba S
    Acta Derm Venereol; 2008; 88(1):69-70. PubMed ID: 18176759
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management.
    Kim DW; Yoon ES; Ji YH; Park SH; Lee BI; Dhong ES
    J Plast Reconstr Aesthet Surg; 2011 Dec; 64(12):1590-5. PubMed ID: 21807574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose of Hyaluronidase to treat over correction by HA filler--a case report.
    Menon H; Thomas M; D'silva J
    J Plast Reconstr Aesthet Surg; 2010 Apr; 63(4):e416-7. PubMed ID: 20133216
    [No Abstract]   [Full Text] [Related]  

  • 15. Angioedema-type swelling and herpes simplex virus reactivation following hyaluronic acid injection for lip augmentation.
    Dougherty AL; Rashid RM; Bangert CA
    J Am Acad Dermatol; 2011 Jul; 65(1):e21-2. PubMed ID: 21679801
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyaluronidase offers an efficacious treatment for inaesthetic hyaluronic acid overcorrection.
    Pierre A; Levy PM
    J Cosmet Dermatol; 2007 Sep; 6(3):159-62. PubMed ID: 17760692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filler complications.
    Junkins-Hopkins JM
    J Am Acad Dermatol; 2010 Oct; 63(4):703-5. PubMed ID: 20846569
    [No Abstract]   [Full Text] [Related]  

  • 18. Two cases of delayed granulomatous reactions to the cosmetic filler Dermalive, a hyaluronic acid and acrylic hydrogel.
    Angus JE; Affleck AG; Leach IH; Millard LG
    Br J Dermatol; 2006 Nov; 155(5):1077-8. PubMed ID: 17034549
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed hypersensitivity reaction to hyaluronic acid dermal filler post-COVID-19 viral infection.
    Shome D; Doshi K; Vadera S; Kapoor R
    J Cosmet Dermatol; 2021 May; 20(5):1549-1550. PubMed ID: 33682241
    [No Abstract]   [Full Text] [Related]  

  • 20. Ischemic oculomotor nerve palsy and skin necrosis caused by vascular embolization after hyaluronic acid filler injection: a case report.
    Kwon SG; Hong JW; Roh TS; Kim YS; Rah DK; Kim SS
    Ann Plast Surg; 2013 Oct; 71(4):333-4. PubMed ID: 23203244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.